scholarly journals A Case of Cutaneous Epstein-Barr Virus-Associated Diffuse Large B-Cell Lymphoma in an Angioimmunoblastic T-Cell Lymphoma

2016 ◽  
Vol 28 (6) ◽  
pp. 789 ◽  
Author(s):  
Mi-Hye Lee ◽  
Ik-Jun Moon ◽  
Woo-Jin Lee ◽  
Chong-Hyun Won ◽  
Sung-Eun Chang ◽  
...  
2008 ◽  
Vol 43 (3) ◽  
pp. 174 ◽  
Author(s):  
Yoon Hee Choi ◽  
Hyo Seog Kim ◽  
Seung Bum Nam ◽  
Hye Jin Kang ◽  
Im Il Na ◽  
...  

2006 ◽  
Vol 130 (11) ◽  
pp. 1707-1711
Author(s):  
Robert C. Hawley ◽  
Milena Cankovic ◽  
Richard J. Zarbo

Abstract Patients with angioimmunoblastic T-cell lymphoma can have profound immune dysfunction and immunodeficiency. Epstein-Barr virus–driven B-cell lymphoid proliferation can occur in angioimmunoblastic T-cell lymphoma, as in other immunodeficiency states. However, few cases of Epstein-Barr virus–positive B-cell lymphoma arising in patients with preexisting angioimmunoblastic T-cell lymphoma have been reported. We report a case of angioimmunoblastic T-cell lymphoma in which diffuse large B-cell lymphoma developed 56 months after the diagnosis of angioimmunoblastic T-cell lymphoma. The patient survived for 9 years after the initial diagnosis of angioimmunoblastic T-cell lymphoma, and molecular studies performed on multiple biopsy specimens during this period revealed the dynamic nature of clonal lymphoid expansion. Epstein-Barr virus latent membrane protein 1 and Epstein-Barr virus– encoded RNA were detected in the diffuse large B-cell lymphoma, suggesting that Epstein-Barr virus may have played a role in the pathogenesis of the diffuse large B-cell lymphoma.


2007 ◽  
Vol 48 (10) ◽  
pp. 2071-2074 ◽  
Author(s):  
Rodrigo O. B. Maegawa ◽  
Sajid Hussain ◽  
Daniel C. Danila ◽  
Julie Teruya-Feldstein ◽  
Robert G. Maki ◽  
...  

2011 ◽  
Vol 52 (10) ◽  
pp. 2027-2030 ◽  
Author(s):  
Sheau-fang yang ◽  
Wen-Yu Chang ◽  
Cheng-Che E. Lan ◽  
Peter G. Isaacson ◽  
Shih-Sung Chuang

2021 ◽  
Author(s):  
Mobin Paul ◽  
Latha Abraham ◽  
MP Sophy ◽  
Dasary Varghese ◽  
Chryselle Olive D'Souza

Epstein Barr virus - positive (EBV+) diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS), is a newly recognized rare aggressive B- cell neoplasm with a wide morphologic spectrum. Metachronously developed B- cell and T- cell composite lymphoma (CL) is quite rare. We report a case of an elderly male who presented with enlarged abdominal lymph nodes and diagnosed as EBV+ DLBCL, NOS. He was started on chemotherapy which had to be discontinued after three cycles due to life threatening Pneumocystis carinii pneumonia and poor performance status. While on follow up, within two years, the patient presented with features of relapse. A repeat histopathological examination of the lymph node showed features of Peripheral T cell lymphoma, not otherwise specified (PTCL, NOS) and the clonality was confirmed by T- cell receptor gamma chain rearrangement assay. More studies are needed to understand the association of EBV+ DLBCL, NOS with other lymphomas.


Sign in / Sign up

Export Citation Format

Share Document